Thus, these results indicate that the AML-SC proteome in CD34 negative AML shares some resemblance with HSCs/HPCs, whereas AML-SCs in CD34 positive AML are largely dissimilar to their healthy counterparts. This evidence concerns the gene CD34 and acute myeloid leukemia.